Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions. A Double-blinded, Single Centre, Randomised, Two-period, Crossover Extension Phase to Evaluate Home Use of Closed-loop Applying Ultra-rapid Insulin Lispro Versus Standard Insulin Lispro (Phase 4).

NCT05257460 is registered in ClinicalTrials.gov with University of Cambridge as lead sponsor.

NCT NCT05257460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05257460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions. A Double-blinded, Single Centre, Randomised, Two-period, Crossover Extension Phase to Evaluate Home Use of Closed-loop Applying Ultra-rapid Insulin Lispro Versus Standard Insulin Lispro (Phase 4).
Lead sponsor
University of Cambridge
Phase
Not applicable
Overall status
Completed
Start date
January 25, 2022
Completion date
March 25, 2023
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes